Measuring the cost-effectiveness of treating rectovaginal and vesicovaginal fistulas: A multicenter global study by the Fistula Foundation

被引:1
|
作者
Rajagopal, Keerthana [1 ,2 ]
Pollaczek, Lindsey [1 ]
Chu, Jesse [1 ]
Mann, Hannah [1 ]
机构
[1] Fistula Fdn, San Jose, CA USA
[2] Fistula Fdn, 1700 The Alameda 300, San Jose, CA 95126 USA
关键词
cost-effectiveness; disability-adjusted life-years; rectovaginal fistula; resource allocation; vesicovaginal fistula; OBSTETRIC FISTULA;
D O I
10.1002/ijgo.15502
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
ObjectiveSurgery for obstetric fistula is a highly effective treatment to restore continence and improve quality of life. However, a lack of data on the cost-effectiveness of this procedure limits prioritization of this essential treatment. This study measures the effectiveness of fistula surgeries using disability-adjusted life years (DALYs) averted.MethodsIn 2021 and 2022, the Fistula Foundation funded 20 179 fistula surgeries and related procedures at 143 hospitals among 27 countries. We calculated DALYs averted specifically for vesicovaginal fistula and rectovaginal fistula procedure types (n = 13 235 surgeries) by using disability weights from the 2019 Global Burden of Disease study. We based cost calculations on direct treatment expenses, including medical supplies, health provider fees, and preoperative and postoperative care. We measured effectiveness using data on the risk of permanent disability, country-specific average life spans, and treatment outcomes.ResultsThe total treatment cost was $7.6 million, and a total of 131 433 DALYs were averted. Thus, the cost per DALY averted-the cost to restore 1 year of healthy life-was $58. For this analysis, we took a cautious approach and weighted only surgeries that resulted in a closed fistula with restored continence. We calculated DALYs averted by country. Limitations of the study include data entry errors inherent in patient logs and lack of long-term outcomes.ConclusionThe current study demonstrates that obstetric fistula surgery, along with having a significant positive impact on maternal health outcomes, is highly cost-effective in comparison with other interventions. The study therefore highlights the benefits of prioritizing fistula treatment as part of the global agenda for maternal health care. Obstetric fistula treatment is highly cost-effective. The current study highlights the benefits of prioritizing fistula treatment as part of the global agenda for maternal health care.
引用
收藏
页码:480 / 486
页数:7
相关论文
共 50 条
  • [21] Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design
    Lammers, Eline M. J.
    Zijlstra, Josee M.
    Retel, Valesca P.
    Aleman, Berthe M. P.
    van Leeuwen, Flora E.
    Nijdam, Annelies
    JMIR RESEARCH PROTOCOLS, 2024, 13
  • [22] Global return on investment and cost-effectiveness of WHO's HEAR interventions for hearing loss: a modelling study
    Tordrup, David
    Smith, Robert
    Kamenov, Kaloyan
    Bertram, Melanie Y.
    Green, Nathan
    Chadha, Shelly
    LANCET GLOBAL HEALTH, 2022, 10 (01): : E46 - E56
  • [23] A Multicenter Randomized Controlled Trial Comparing Safety, Efficacy, and Cost-effectiveness of the Surgisis Anal Fistula Plug Versus Surgeon's Preference for Transsphincteric Fistula-in-Ano The FIAT Trial
    Jayne, David G.
    Scholefield, John
    Tolan, Damian
    Gray, Richard
    Senapati, Asha
    Hulme, Claire T.
    Sutton, Andrew J.
    Handley, Kelly
    Hewitt, Catherine A.
    Kaur, Manjinder
    Magill, Laura
    ANNALS OF SURGERY, 2021, 273 (03) : 433 - 441
  • [24] Cost-effectiveness of screening and treating alcohol use and depression among people living with HIV in Zimbabwe: a mathematical modeling study
    Su, Jasmine I-Shin
    Yeo, Yao-rui
    Jeetoo, Mellesia
    Morojele, Neo K.
    Francis, Joel M.
    Shenoi, Sheela
    Braithwaite, R. Scott
    BMC MEDICINE, 2024, 22 (01):
  • [25] Cost-effectiveness of endoscopic ultrasonography in upper GI submucosal tumors: A prospective multicenter study of the German EUS-club.
    Meining, A
    Roesch, T
    Siess, M
    Sahai, A
    Kapfer, B
    Ulm, K
    GASTROINTESTINAL ENDOSCOPY, 2000, 51 (04) : AB174 - AB174
  • [26] Treatment burden and cost-effectiveness analysis of the neoadjuvant CROSS regimen in esophageal squamous cell carcinoma: a multicenter retrospective study
    Gao, Xing
    Yang, Zhi-Hao
    Cheng, Yi-Hsuan
    Chi, Chun-Ling
    Yang, Tzu-Yi
    Chuang, Kai-Hao
    Wu, Chiao-En
    van Lanschot, Joseph Jan-Baptist
    Wen, Yu-Wen
    Chao, Yin-Kai
    DISEASES OF THE ESOPHAGUS, 2023, 36 (11)
  • [27] Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: A GBECAM multicenter retrospective study.
    Oliveira, Leandro Carvalho
    Cury Megid, Thais Baccili
    Rosa, Daniela Dornelles
    da Silva Magliano, Carlos Alberto
    Suzuki, Daniele Assad
    Argolo, Daniel F.
    Sanches, Solange Moraes
    Testa, Laura
    Bines, Jose
    Kaliks, Rafael Alioska
    Caleffi, Maira
    Gagliato, Debora De Melo
    Sahade, Marina
    Barroso-Sousa, Romualdo
    Correa, Tatiana Strava
    Shimada, Andrea
    Katz, Artur
    Mano, Max S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18822 - E18822
  • [28] A METHOD FOR ASSESSING THE CLINICAL-PERFORMANCE AND COST-EFFECTIVENESS OF INTENSIVE-CARE UNITS - A MULTICENTER INCEPTION COHORT STUDY
    RAPOPORT, J
    TERES, D
    LEMESHOW, S
    GEHLBACH, S
    CRITICAL CARE MEDICINE, 1994, 22 (09) : 1385 - 1391
  • [29] Comment on: "A Multicenter Randomized Controlled Trial Comparing Safety, Efficacy, and Cost-effectiveness of the Surgisis Anal Fistula Plug Versus Surgeon's Preference for Transsphincteric Fistula-in-Ano The FIAT Trial''
    Moran, Emily C.
    Perin, Giordano
    Balasubramanian, Saba P.
    ANNALS OF SURGERY, 2021, 274 (06) : E930 - E931
  • [30] Higher diagnostic accuracy and cost-effectiveness using procalcitonin in the treatment of emergency medicine patients with fever (The HiTEMP study): A multicenter randomized study
    van der Does Y.
    Limper M.
    Schuit S.C.E.
    Poley M.J.
    van Rosmalen J.
    Ramakers C.
    Patka P.
    van Gorp E.C.M.
    Rood P.P.M.
    BMC Emergency Medicine, 16 (1)